Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, March 23, 2016
Vetter, a global contract development and manufacturing organization (CDMO) for the development, commercial manufacturing and final packaging of aseptically prefilled drug-delivery systems, has announced the construction of a new building at a ground...
read more
Wednesday, March 23, 2016
Lundbeck, a global pharmaceutical company, has chosen ArisGlobal® to complete the upgrade of its regulatory and safety systems on the agOnDemand™ platform.
read more
WuXi AppTec an open-access R&D capability and technology platform company serving the global pharmaceutical, biotechnology and medical device industries, has announced the opening of its branch office in Seoul, South Korea.
read more
The Truvada (emtricitabine/tenofovir disoproxil fumarate) tablet label was recently updated to expand the indication to include pediatric patients weighing at least 12 kilograms and the addition of the following strength tablets (100/150 mg, 133/200 ...
read more
Dr. Reddy's Laboratories and XenoPort have entered into a license agreement pursuant to which Dr. Reddy’s Laboratories will be granted exclusive U.S. rights for the development and commercialization of XenoPort’s clinical-stage oral new chemical ...
read more
CRF Health, a provider of eCOA solutions for the life sciences industry, has announced its TrialMax® eCOA platform has been selected by a leading sponsor in the field of diabetes research.
read more
Eagle Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) has denied Eagle’s request for seven years of orphan drug exclusivity in the U.S., for BENDEKA™ (bendamustine hydrochloride injection, or bendamustine HCI), a liquid...
read more
Greenphire, a provider of global clinical payment solutions, has appointed Wayne Baker as Chief Commercial Officer to lead the commercial strategy of the rapidly growing organization worldwide.
read more
Aralez Pharmaceuticals has announced that the U.S. Food and Drug Administration ("FDA") has acknowledged acceptance of the New Drug Application ("NDA") for its investigational candidate, YOSPRALA™(PA32540/PA8140) for the secondary prevention of ...
read more
Wednesday, March 30, 2016
Crown Bioscience Inc., a wholly owned subsidiary of Crown Bioscience International, a global drug discovery and development solutions company providing translational platforms to advance oncology and metabolic disease research, has announced the ...
read more
Wednesday, March 30, 2016
Envigo has been granted full accreditation for its Horst, Netherlands site from the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) International Council. AAALAC informed Envigo that that the criteria for achieving ...
read more
Wednesday, March 30, 2016
Ora, Inc. has announced the addition of Simon Chandler, PhD as Senior Director to lead regulatory and clinical operations for Europe. Simon will be based in the UK.
read more
Wednesday, March 30, 2016
X-Chem, a privately held biotechnology company applying its DNA-Encoded X-Chem (DEX™) drug discovery platform to generate novel therapeutics, has announced that a licensing option with Janssen Biotech, Inc., one of the Janssen Pharmaceutical ...
read more
Wednesday, March 30, 2016
Greater acceptance of biosimilar medicines in a growing number of therapy areas and an active pipeline of 56 new products in clinical development are expected to deliver total savings of as much as $110 billion to health systems across Europe and the...
read more
Wednesday, March 30, 2016
Biodextris Inc. has announced its suite of services and commitment to building a full service contract organization. The new contract research organization (CRO) provides analytical and process development services for vaccines and biologics ...
read more